310 insimbi engenastainless capillary coil tubing chemical component, Indima ye-dystrophin glycoprotein complexes kwi-mechanotransduction yeeseli zemisipha.

Enkosi ngokundwendwela i-Nature.com.Usebenzisa uguqulelo lwebrawuza enenkxaso enyiniweyo yeCSS.Ngowona mava angcono, sicebisa ukuba usebenzise isikhangeli esihlaziyiweyo (okanye uvale iModi yokuThelela kwi-Internet Explorer).Ukongeza, ukuqinisekisa inkxaso eqhubekayo, sibonisa indawo ngaphandle kwezitayela kunye neJavaScript.
Izilayidi ezibonisa amanqaku amathathu kwisilayidi ngasinye.Sebenzisa amaqhosha angasemva nalandelayo ukuhamba kwizilayidi, okanye amaqhosha okulawula isilayidi ekupheleni ukuya kwisilayidi ngasinye.

310 ababoneleli ngetyhubhu yentsimbi yecapillary coil

I-Dystrophin yiprotheni ephambili ye-dystrophin-glycoprotein complex (DGC) kwi-skeletal muscle kunye ne-cardiomyocytes.I-Dystrophin ibophelela i-actin cytoskeleton kwi-matrix ye-extracellular (ECM).Ukuqhawulwa koxhulumaniso phakathi kwe-matrix ye-extracellular kunye ne-intracellular cytoskeleton ingaba nemiphumo emibi kwi-homeostasis yeeseli ze-muscle skeletal, ezikhokelela kwinani le-muscular dystrophies.Ukongeza, ukulahleka kwe-DGCs esebenzayo kukhokelela kwi-cardiomyopathy eqhubekayo kunye nokufa kwangaphambi kwexesha.I-Dystrophin isebenza njengentwasahlobo ye-molecular kwaye i-DHA idlala indima ebalulekileyo ekugcineni ingqibelelo ye-sarcolemma.Ngaphezu koko, ubungqina buqokelelana ngokunxibelelanisa i-DGC nokusayinwa koomatshini, nangona le ndima ihlala ingaqondwa kakuhle.Eli nqaku lokuphonononga lijolise ekunikeni umbono wanamhlanje we-DGCs kunye nendima yabo kwi-mechanotransduction.Siqala sixoxe ngobudlelwane obunzima phakathi kwe-muscle cell mechanics kunye nomsebenzi, kwaye emva koko sihlolisise uphando olutshanje malunga nendima ye-dystrophin glycoprotein eyinkimbinkimbi kwi-mechanotransduction kunye nokugcinwa kwe-muscle cell biomechanical integrity.Ekugqibeleni, sihlaziya uncwadi lwangoku ukuze siqonde indlela i-DGC yokubonisa i-intersecting kunye ne-mechanosignaling pathways ukugqamisa iindawo ezinokuthi zingenelele kwixesha elizayo, ngokugxininisa ngokukodwa kwi-cardiomyopathy.
Iiseli zinxibelelana rhoqo kunye ne-microenvironment yazo, kwaye i-dialogue yeendlela ezimbini phakathi kwabo iyimfuneko ekutolikeni nasekudityanisweni kolwazi lwe-biomechanical.I-Biomechanics ilawula iziganeko eziphambili ezilandelayo (umzekelo, ukulungiswa kwakhona kwe-cytoskeletal) ngokulawula i-phenotype yeselula ngokubanzi kwindawo kunye nexesha.Eyona nto iphambili kule nkqubo kwi-cardiomyocytes yindawo yeendleko, ummandla apho i-sarcolemma idibanisa kwi-sarcomere ehlanganiswe ne-integrin-talin-vinculin kunye ne-dystrophin-glycoprotein (DGC) complexes.Incanyathiselwe kwi-cytoskeleton ye-intracellular, ezi zi-discrete focal adhesions (FAs) zisasaza i-cascade ye-biomechanical kunye neenguqu ze-biochemical zeselula ezilawula ukuhlukana, ukwanda, i-organogenesis, ukufuduka, ukuqhubela phambili kwesifo, kunye nokunye.Ukuguqulwa kwamandla e-biomechanical kwi-biochemical kunye / okanye (epi) utshintsho lwezofuzo luyaziwa ngokuba yi-mechanotransduction1.
I-integrin transmembrane receptor 2 sele iyaziwa ngokuba yi-anchor i-matrix ye-extracellular kwiiseli kunye nokudibanisa kokubili ukubonakaliswa kwangaphakathi nangaphandle.Ngokuhambelana nee-interins, ii-DGCs zibophelela i-ECM kwi-cytoskeleton, ukuseka ikhonkco elibalulekileyo phakathi kwangaphandle nangaphakathi kweseli3.I-dystrophin yobude obupheleleyo (i-Dp427) ibonakaliswe ngokuyinhloko kwi-cardiac kunye ne-skeletal muscle, kodwa iphinda ibonwe kwizicubu zenkqubo ye-nervous central, kuquka i-retina kunye ne-Purkinje tissue4.Ukuguqulwa kwee-interins kunye ne-DGC kucingelwa ukuba yimbangela ye-muscular dystrophy kunye ne-progressive dilated cardiomyopathy (DCM) (Itheyibhile 1) 5,6.Ngokukodwa, iinguqu ze-DMD ezifaka i-protein ye-dystrophin ephakathi kwee-DGCs zibangela i-Duchenne muscular dystrophy (DMD)7.I-DGC iqulethwe ngama-subcomplexes amaninzi aquka i-α- kunye ne-β-dystroglycan (α/β-DG), i-sarcoglycan-sarcospan, i-sytrophin, kunye ne-dystrophin8.
I-Dystrophin yiprotheni ye-cytoskeletal encoded yi-DMD (Xp21.1-Xp22) edlala indima ebalulekileyo ekugcineni i-DGC.I-DGC igcina ingqibelelo ye-sarcolemma, i-membrane ye-plasma ye-striated muscle tissue.I-Dystrophin iphinda inciphise umonakalo obangelwa kukunqanda ngokusebenza njenge-molecular spring kunye ne-molecular scaffold9,10.I-dystrophin yobude obugcweleyo inobunzima be-molecular ye-427 kDa, nangona kunjalo, ngenxa yabaninzi abagqugquzeli bangaphakathi kwi-DMD, kukho ii-isoforms ze-truncated zendalo ezininzi, kuquka i-Dp7111.
Iiprotheyini ze-accessory ziye zaboniswa ukuba zenzeke kwi-dystrophin, kubandakanywa i-mechanotransducers yokwenene njenge-neuronal nitric oxide synthase (nNOS), iprotheyini edibeneyo ye-Yes (YAP), kunye ne-caveolin-3, ngaloo ndlela imele amacandelo abalulekileyo okubonakaliswa kweselula.I-Compounds 12, 13, 14. Ukongeza kwi-adhesion, indlela yeselula ehambelana nokusebenzisana phakathi kweeseli kunye ne-matrix, eyenziwe ngama-integrin kunye neethagethi zabo ezisezantsi, ezi zimbini zimbini zimela ukudibanisa phakathi "ngaphakathi" kunye "ngaphandle" kweseli. .Ukukhusela oku kuncamathele kwintshabalalo engaqhelekanga kubalulekile ekuziphatheni kweeseli nasekuphileni.Ukongezelela, inkxaso yedatha yokuba i-dystrophin i-modulator ye-ion ye-mechanosensitive channels, kubandakanywa iziteshi ezisetyenzisiweyo ezilula, ngakumbi i-L-type Ca2 + iziteshi kunye ne-TRPC 15 iziteshi.
Nangona i-dystrophin ibalulekile kumsebenzi we-homeostatic we-striated muscle cells, iindlela ezichanekileyo ezixhasayo azicaci kakuhle, ngokukodwa indima ye-dystrophin kunye nokukwazi kwayo ukusebenza njenge-mechanosensor kunye nomkhuseli womatshini.Ngenxa yokulahleka kwe-dystrophin, kuye kwavela imibuzo emininzi engaphendulwanga, kubandakanywa: ngaba iiprotheyini ze-mechanosensitive ezifana ne-YAP kunye ne-AMPK ephosakeleyo kwi-sarcolemma;Ngaba kukho i-crosstalk ene-interins, iimeko ezinokukhokelela kwi-mechanotransduction engaqhelekanga?Zonke ezi mpawu zinokuba negalelo kwi-phenotype ye-DCM enzima ebonwa kwizigulane ezine-DMD.
Ukongezelela, umbutho weenguqu kwi-biomechanics yeselula kunye ne-DMD yonke phenotype ineempembelelo ezibalulekileyo zeklinikhi.I-DMD i-X-linked muscular dystrophy echaphazela amadoda e-1: 3500-5000, ebonakaliswe ngokulahleka kwangaphambili kokuhamba (I-biomechanics yokulahlekelwa kwe-dystrophin ayizange ichazwe ngokupheleleyo, kwaye apha sihlaziya ubungqina obuxhasa ingcamango yokuba i-dystrophin ngokwenene idlala indima ye-mechanoprotective, oko kukuthi, ukugcina ingqibelelo ye-sarcolemma, kwaye ibalulekile kwi-mechanotransduction.Ukongezelela, sihlolisise ubungqina obubonisa ukuba i-crosstalk ebalulekileyo kunye ne-interins, ngokukodwa i-laminin α7β1D kwiiseli ze-striated muscle.
Ukufakwa kunye nokususwa kuxanduva lwenani elikhulu lokuguqulwa kwe-DMD, kunye ne-72% yeenguqu ezibangelwa ukuguqulwa okunjalo19.Ngokonyango, i-DMD ibonisa ebuntwaneni (≤5 iminyaka) kunye ne-hypotension, uphawu oluhle lwe-Gower, ukulibaziseka ukuqhubela phambili kweenguqu ezinxulumene neminyaka yobudala, ukukhubazeka kwengqondo, kunye ne-skeletal muscle atrophy.Uxinzelelo lokuphefumula luye lwaba yimbangela ehamba phambili yokufa kwizigulane ze-DMD, kodwa ukunakekelwa kwenkxaso ephuculweyo (i-corticosteroids, uxinzelelo oluqhubekayo lwe-airway) luye lwandisa ixesha lokuphila kwezi zigulana, kwaye iminyaka ephakathi yezigulane ze-DMD ezizalwe emva kwe-1990 yi-28.1 iminyaka ye-20, i-21 ..Nangona kunjalo, njengoko ukusinda kwesigulane kunyuka, i-prognosis ye-DCM eqhubekayo imbi kakhulu xa kuthelekiswa nezinye i-cardiomyopathies16, ekhokelela ekupheleni kokuphelelwa yintliziyo, okwangoku iyona nto ibangela ukufa, kubalwa malunga ne-50% ye-DMD yokufa17,18.
I-DCM eqhubekayo ibonakala ngokunyuka kwe-ventricular dilatation kunye nokuthotyelwa, ukuncipha kwe-ventricular, ukunyuka kwe-fibrofatty infiltration, ukunciphisa umsebenzi we-systolic, kunye nokunyuka kwe-arrhythmias.Iqondo le-DCM kwizigulane ezine-DMD liphantse lifike kwindalo yonke ebusheni (90% ukuya kwi-18 yeminyaka ubudala), kodwa ikhona malunga ne-59% yezigulane nge-10 yeminyaka yobudala8,22.Ukujongana nalo mba kubalulekile njengoko iqhezu le-left ventricular ejection liye lahla ngokuthe ngcembe kwireyithi ye-1.6% ngonyaka23.
I-cardiac arrhythmias ixhaphake kwizigulane ezine-DMD, ngakumbi i-sinus tachycardia kunye ne-ventricular tachycardia, kwaye yimbangela yokufa kwentliziyo ngokukhawuleza22.I-Arrhythmias yimiphumo yokungena kwe-fibrofatty, ngokukodwa kwi-ventricle ye-subbasal ekhohlo, ephazamisa i-circuitry yokubuya kunye ne- [Ca2 +] i-process dysfunction kunye ne-ion channel dysfunction24,25.Ukuqatshelwa kokunikezelwa kwentliziyo yeklinikhi kubalulekile, njengoko izicwangciso zonyango zakwangoko zinokulibazisa ukuqala kwe-DCM enzima.
Ukubaluleka kokunyanga ukungasebenzi kwentliziyo kunye nokukhubazeka kwemisipha kuboniswe kwisifundo esinomdla esasebenzisa imodeli yemouse ye-DMD ebizwa ngokuba yi-mdx26 ukufunda imiphumo yokuphucula izicubu ze-skeletal muscle ngaphandle kokujongana neengxaki zentliziyo ezikhoyo kwi-DMD.Apha, ababhali babonise ukunyuka kwe-5-fold paradoxical kwi-cardiac dysfunction emva kokuphuculwa kwe-skeletal muscle, kwaye iigundane zibe nokunciphisa okukhulu kwi-fraction26 ye-ejection.Ukuphuculwa komsebenzi we-skeletal muscle kuvumela umsebenzi ophezulu womzimba ukubeka uxinzelelo olungakumbi kwi-myocardium, okwenza kube lula ukungasebenzi ngokubanzi.Oku kugxininisa ukubaluleka kokunyanga izigulane ze-DMD ngokubanzi kunye nokulumkisa ngonyango lwe-muscle ye-skeletal yodwa.
Ii-DGC zenza imisebenzi emininzi eyongezelelweyo, oko kukuthi, ukubonelela ngozinzo lwesakhiwo kwi-sarcolemma, ibe yi-scaffold ye-molecular esebenza njengekhonkco lokubonisa, ukulawula iziteshi ze-ion ze-mechanosensitive, i-core of costal mechanotransduction, kunye nokuthatha inxaxheba ekuhanjisweni kwamandla asecaleni kummandla we iimbambo (Umfanekiso 1b)..I-Dystrophin idlala indima ephambili kulo buchule, kwaye ngenxa yobukho babagqugquzeli abaninzi bangaphakathi, kukho ii-isoforms ezahlukeneyo, nganye idlala indima eyahlukileyo kwizicubu ezahlukeneyo.Ukubonakaliswa kwezicubu ezihlukeneyo ze-dystrophin isoforms ezahlukeneyo zixhasa ingcamango yokuba i-isoform nganye idlala indima eyahlukileyo.Ngokomzekelo, izicubu zentliziyo zivakalisa ubude obupheleleyo (i-Dp427m) kunye ne-Dp71m emfutshane ye-isoform ye-dystrophin, ngelixa i-skeletal tissue ichaza kuphela eyokuqala kwezi zimbini.Ukuqwalaselwa kwendima ye-subtype nganye kunokutyhila kuphela umsebenzi wayo we-physiological, kodwa kunye ne-pathogenesis ye-muscular dystrophy.
Ukubonakaliswa kweSchematic ye-dystrophin yobude obupheleleyo (Dp427m) kunye ne-isoform encinci, encinci ye-Dp71.I-Dystrophin ine-spectrin ye-24 iphinda ihlukaniswe ngama-loops amane, kunye nesizinda se-actin-binding (ABD), isizinda se-cysteine-rich (CR), kunye ne-C-terminus (CT).Amaqabane abalulekileyo abophekileyo achongiwe, kubandakanywa i-microtubules (MTs) kunye ne-sarcolemma.Zininzi ii-isoforms ze-Dp71, i-Dp71m ibhekisa kwizicubu zezihlunu kwaye i-Dp71b ibhekisa kwi-isoform ye-nervous tissue.Ngokukodwa, i-Dp71f ibhekisa kwi-cytoplasmic isoform ye-neurons.b I-dystrophin-glycoprotein complex (DHA) ifumaneka kwi-sarcolemma iyonke.Amandla e-Biomechanical atshintsha phakathi kwe-ECM kunye ne-F-actin.Qaphela i-crosstalk enokubakho phakathi kwe-DGCs kunye ne-integrin adhesion, i-Dp71 inokudlala indima ekugxininiseni ukunamathela.Yenziwe ngeBiorender.com.
I-DMD yeyona nto ixhaphakileyo ye-muscular dystrophy kwaye ibangelwa ziinguqu kwi-DMD.Nangona kunjalo, ukuqonda ngokupheleleyo ukuqonda kwethu kwangoku kwendima ye-anti-dystrophin, kubalulekile ukuyibeka kumxholo we-DGC yonke.Ke, ezinye iiproteni ezibandakanyekayo ziya kuchazwa ngokufutshane.Ukubunjwa kweprotheyini ye-DGC yaqala ukufundwa ngasekupheleni kweminyaka yee-1980, ngokuqwalasela ngokukodwa kwi-dystrophin.I-Koenig27,28, i-Hoffman29 kunye ne-Ervasti30 yenza ukufumanisa okubalulekileyo ngokuchonga i-dystrophin, iprotheni ye-427 kDa kwi-muscle striated31.
Emva koko, ezinye ii-subcomplexes zaboniswa ukuba zinxulunyaniswa ne-dystrophin, kubandakanya i-sarcoglycan, i-transsyn, i-dystrophin subcomplex, i-dysbrevin, kunye ne-sytrophins8, ezidibene zenza imodeli yangoku ye-DGC.Eli candelo liya kuqala ukusabalalisa ubungqina bendima ye-DGC kwimbono ye-mechanosensory ngelixa uhlola amacandelo ngabanye ngokubanzi.
I-isoform ye-dystrophin yobude obupheleleyo ekhoyo kwi-striated muscle tissue yi-Dp427m (umzekelo, "m" ye-muscle ukuze iyahlula kwingqondo) kwaye yiprotheni enkulu emile njengentonga eneendawo ezine ezisebenzayo eziphantsi kwe-cardiomyocyte sarcolemma, ngakumbi kwingingqi yeendleko. 29, 32. I-Dp427m, efakwe kwi-DMD gene kwi-Xp21.1, iqulethe ii-exons ze-79 ezenziwe kwii-megabases ze-2.2 kwaye ngoko ke i-gene enkulu kwi-genome8 yethu.
Abagqugquzeli abaninzi bangaphakathi kwi-DMD bavelisa i-multiple truncated dystrophin isoforms, ezinye zazo ziyizicubu ezithile.Xa kuthelekiswa ne-Dp427m, i-Dp71m icuthwe kakhulu kwaye ayinayo idomeyini ephindayo ye-spectrin okanye i-N-terminal ABD domain.Nangona kunjalo, i-Dp71m igcina ulwakhiwo olubophelelayo lwe-C-terminal.Kwi-cardiomyocytes, indima ye-Dp71m ayicacanga, kodwa ibonakaliswe ukuba ifakwe kwi-tubules ye-T, iphakamisa ukuba inokunceda ekulawuleni ukudibanisa kwe-excitation-contraction 33,34,35.Kulwazi lwethu, ukufunyanwa kwamva nje kwe-Dp71m kwizicubu zentliziyo kuye kwafumana ingqwalasela encinci, kodwa ezinye izifundo zibonisa ukuba zidibene neziteshi ze-ion ezisetyenzisiweyo, kwaye uMasubuchi ucebise ukuba unokudlala indima ekulawuleni i-nNOS33., 36. Ngokwenza njalo, i-Dp71 ifumene ingqwalasela ebalulekileyo kwi-neurophysiology kunye nophando lweplatelet, iindawo ezinokubonelela ngendima kwi-cardiomyocytes37,38,39.
Kwizicubu zovalo, i-Dp71b isoform ibonakaliswa ikakhulu, kunye ne-14 isoforms exeliweyo38.Ukususwa kwe-Dp71b, umlawuli obalulekileyo we-aquaporin 4 kunye ne-Kir4.1 iziteshi ze-potassium kwinkqubo ye-nervous central, ibonakaliswe ukuguqula umqobo we-blood-brain barrier permeability40.Ukunikezelwa kwendima ye-Dp71b kulawulo lwe-ion channel, i-Dp71m inokudlala indima efanayo kwi-cardiomyocytes.
Ubukho be-DGC kwi-costal ganglia ngokukhawuleza bubonisa indima kwi-mechanotransduction, kwaye ngokwenene ibonakaliswe ngokubambisana kunye ne-integrin-talin-vinculin complexes 41.Ngaphezu koko, kunikezelwa ukuba icandelo leendleko ligxininise kwi-mechanotransduction eguquguqukayo, indawo yokuhlala ye-Dp427m apha igxininisa indima yayo ekukhuseleni iiseli kumonakalo obangelwa kukuchithwa.Ngaphezu koko, i-Dp427m isebenzisana ne-actin kunye ne-microtubule cytoskeleton, ngaloo ndlela igqibezela uxhulumaniso phakathi kwendawo ye-intracellular kunye ne-extracellular matrix.
I-N-terminus equkethe i-actin-binding domain 1 (ABD1) iqulethe i-domain ye-homology ye-callodulin (CH) efunekayo ekusebenzisaneni ne-F-actin kunye ne-anchoring i-γ-actin isoform kwi-sarcolemma42,43.I-Dystrophin inokufaka isandla kwi-viscoelasticity yonke ye-cardiomyocytes ngokunamathela kwi-cytoskeleton ye-subsarcolemmal, kwaye indawo yayo kwi-costal ganglia isekela ukubandakanyeka kwayo kwi-mechanotransduction kunye ne-mechanoprotection44,45.
Isizinda esisembindini sineeproteni ezingama-24 eziphinda-phinda ezifana ne-spectrin, nganye kuzo imalunga ne-100 yeentsalela ze-amino acid ubude.Ukuphindaphinda kwe-spectrin kuhlanganiswe kunye neendawo ezine zehinge, zinika ukuguquguquka kweprotheyini kunye neqondo eliphezulu lokwandiswa.Ukuphindaphinda kwe-Dystrophin spectrin kunokuvela ngaphakathi koluhlu lwe-physiological of forces (15-30 pN) ukusuka kwi-21 nm ukuya kwi-84 nm, imikhosi enokufezekiswa kwi-myosin contraction 46.Ezi mpawu zesizinda esiphindayo se-spectrin sivumela i-dystrophin ukuba isebenze njenge-molecular shock absorber.
Intonga ephakathi ye-Dp427m iqinisekisa indawo yayo kwi-sarcolemma, ngokukodwa, ngokusebenzisa i-hydrophobic kunye ne-electrostatic interactions kunye ne-phosphatidylserine 47,48.Kuyathakazelisa ukuba i-core central ye-dystrophin isebenzisana ngokuhlukileyo kunye ne-sarcolemma phospholipids kwi-skeletal and cardiac tissues, mhlawumbi ebonisa iipatheni ezahlukeneyo zasentwasahlobo.ebaluleke kakhulu, ngelixa izihlunu zamathambo nazo zihambelana ne-R10-R1249.
Ukubophelela kwi-γ-actin cytoskeleton idinga i-ABD2 spectrin iphinda i-11-17 indawo, equkethe iintsalela ze-amino acid ezisisiseko kwaye zihluke kwi-domain ye-F-actin-binding CH.I-Microtubules isebenzisana ngokuthe ngqo ne-core domain ye-dystrophin, le ntsebenziswano idinga i-residues ye-spectrin iphinda i-4-15 kunye ne-20-23, kwaye ubukho be-ankyrin B bufunekayo ukukhusela ukubunjwa kwe-microtubules kule ndawo.Imibhobho ayikho 50,51,52.I-gap phakathi kwe-microtubules kunye ne-dystrophin ibonakaliswe ukwandisa i-DMD pathology ngokunyusa iintlobo ze-oksijini ezisebenzayo (X-ROS).
Isizinda se-CR nge-ankyrin B yenye i-anchor ye-sarcolemmal phospholipids52.I-Ankyrin-B kunye ne-ankyrin-G ziyafuneka kwi-rib localization ye-dystrophin / DGC, kwaye ukungabikho kwazo kubangela i-diffuse sarcolemmal pattern ye-DGC52.
I-domain ye-CR iqulethe i-WW ebophelelayo i-domain esebenzisana ngqo ne-PPxY ebophelelayo i-motif ye-β-DG.Ngokunamathela kwi-complex ye-dystrophin-glycan, i-dystrophin igqiba ikhonkco phakathi kwangaphakathi nangaphandle kweseli54.Olu xhulumaniso lubaluleke kakhulu kwi-striated muscle, njengoko kuboniswa yinto yokuba ukuphazamiseka koqhagamshelwano phakathi kwe-ECM kunye nengaphakathi leseli kukhokelela kubomi bokunciphisa i-muscular dystrophy.
Ekugqibeleni, i-domain ye-CT yindawo egcinwe kakhulu eyenza i-helix edibeneyo kwaye ibaluleke kakhulu ekubopheni i-α-dystrobrevin kunye ne-α1-, β1-syntrophins55,56.I-α-dystrobrevin ibophelela kwi-CT domain ye-dystrophin kwaye inikezela ukuchasana okongeziweyo kwi-dystrophin kwi-sarcolemma57.
Ngexesha lophuhliso lwe-embryonic kunye ne-fetus, i-Utrophin ibonakaliswa ngokubanzi kwizicubu ezahlukeneyo, kubandakanywa iiseli ze-endothelial, izicubu ze-nervous, kunye ne-striated muscle tissue58.I-Utrophin iboniswa yi-UTRN efumaneka kwi-chromosome 6q kwaye i-dystrophin autolog ene-80% ye-protein homology.Ngexesha lophuhliso, i-utrophin ibekwe kwindawo ye-sarcolemma kodwa icinezelwe ngokubonakalayo kwizicubu ze-postnatal striated muscle, apho ithathelwa indawo yi-dystrophin.Emva kokuzalwa, indawo ye-utrophin inqunyelwe kwii-tendon kunye ne-neuromuscular junctions ye-skeletal muscles58,59.
Amaqabane abophezelayo e-Utrophin ngokubanzi afana nalawo e-dystrophins, nangona ezinye iiyantlukwano eziphambili zichazwe.Ngokomzekelo, i-dystrophin isebenzisana ne-β-DG ngokusebenzisa isizinda sayo se-WW, esizinziswe yi-domain ye-ZZ (egama layo likwazi ukubopha i-zinc ions ezimbini) ngaphakathi kwendawo ye-CT, apho i-cysteic acid i-residues 3307-3354 ibaluleke kakhulu kule ntsebenziswano60 ., 61. I-Utrophin iphinda ibophelele kwi-β-DG nge-domain ye-WW / ZZ, kodwa iintsalela ezichanekileyo ezixhasa le ntsebenziswano zihluke kwiintsalela ze-dystrophin (3307-3345 kwi-dystrophin kunye ne-3064-3102 kwi-utrophin) 60,61.Okubalulekileyo, ukubophelela kwe-utrophin kwi-β-DG kwakumalunga ne-2-fold ephantsi xa kuthelekiswa ne-dystrophin 61. I-Dystrophin iye yaxelwa ukuba ibophe kwi-F-actin nge-spectrin iphinda i-11-17, ngelixa iziza ezifanayo kwi-utrophin azikwazi ukubopha kwi-F-actin, nangona kunjalo. ugxininiso oluphezulu, kodwa banokusebenzisana nge-CH-domains zabo.Isenzo 62,63,64.Ekugqibeleni, ngokungafaniyo ne-dystrophin, i-utrophin ayikwazi ukubopha kwi-microtubules51.
I-Biomechanically, ukuphindaphinda kwe-utrophin spectrin kunepateni eyahlukileyo engabonakaliyo xa kuthelekiswa ne-dystrophin65.I-Utrophin-spectrin iphinda ukuthunyelwa kumandla aphezulu, afana ne-titin kodwa kungekhona i-dystrophin65.Oku kuhambelana nendawo yayo kunye nendima ekuhanjisweni kwamandla okuqina okuguquguqukayo kwi-tendon junctions, kodwa inokwenza i-utrophin ingafaneleki ukuba isebenze njengentwasahlobo ye-molecular in buffering forces eyenziwa yi-contraction 65.Kuthatyathwe kunye, ezi datha zibonisa ukuba i-mechanotransduction kunye ne-mechanobuffering capabilities ingatshintshwa phambi kwe-utrophin overexpression, ingakumbi inikwe amaqabane ahlukeneyo abophezelayo / iindlela, nangona kunjalo oku kufuna uphando olongezelelweyo lokulinga.
Ukususela kumbono wokusebenza, into yokuba i-utrophin ikholelwa ukuba ineempembelelo ezifanayo kwi-dystrophin yenza ukuba ibe yinto ekujoliswe kuyo yonyango ye-DMD66,67.Enyanisweni, ezinye izigulane ze-DMD ziye zaboniswa ukuba zigqithise i-utrophin, mhlawumbi njengendlela yokuhlawulela, kwaye i-phenotype ibuyiselwe ngempumelelo kwimodeli yegundane kunye ne-utrophin overexpression 68.Ngelixa ukunyuswa kwe-utrophin isicwangciso esinokwenzeka sonyango, ukuqwalaselwa kwentlukwano esemthethweni kunye nokusebenza phakathi kwe-utrophin kunye ne-dystrophin kunye nokusetyenziswa kokunyanzeliswa kwe-overexpression kunye neendawo ezifanelekileyo kunye ne-sarcolemma yenza ukuba isicwangciso sexesha elide le-utrophin lisacaca.Ngokucacileyo, abathwali besifazane babonisa umzekelo we-mosaic we-utrophin expression, kwaye umlinganiselo phakathi kwe-dystrophin kunye ne-utrophin inokuchaphazela iqondo le-cardiomyopathy ehlanjululweyo kwezi zigulana, i-69 nangona imizekelo ye-murine yabathwali ibonisiwe..
I-subcomplex ye-dystroglycan iqukethe iiprotheni ezimbini, i-α- kunye ne-β-dystroglycan (α-, β-DG), zombini ibhalwe kwi-DAG1 gene kwaye emva kokuguqulelwa kokuguqulelwa kwiiprotheni ezimbini ze-71.I-α-DG i-glycosylated kakhulu kwi-extracellular aspect ye-DGCs kwaye isebenzisana ngokuthe ngqo kunye neentsalela zeproline kwi-lamin α2 kunye ne-agrin72 kunye ne-picaculin73 kunye nommandla we-CT / CR we-dystrophin73,74,75,76.I-O-linked glycosylation, ngokukodwa i-serine residues, iyadingeka ekusebenzisaneni kwayo ne-ECM.Indlela ye-glycosylation ibandakanya ezininzi ii-enzyme eziguqulwayo zikhokelela kwi-muscular dystrophy (jonga kwakhona iThebhile 1).Ezi ziquka i-O-mannosyltransferase POMT2, i-fucutin kunye neprotheni ehlobene ne-fucutin (FKRP), i-ribitol phosphotransferases ezimbini ezongeza i-tandem ribitol phosphates kwi-core glycan, kunye ne-LARGE1 iprotheni eyongeza i-xylose kunye ne-glucose.Linear uronic acid polysaccharide, eyaziwa ngokuba matrix glycan ekupheleni glycan77.I-FKRP ibandakanyeka ekuphuhliseni nasekugcinweni kwe-ECM, kwaye ukuguqulwa kwayo kukhokelela ekunciphiseni ukubonakaliswa kwe-laminin α2 kunye ne-α-DG77,78,79.Ukongeza, i-FKRP inokwalathisa ukubunjwa kwe-basal lamina kunye ne-cardiac extracellular matrix nge-glycosylated fibronectin 80.
I-β-DG iqulethe i-PPxY ebophelelayo i-motif eyenza indawo ngqo kwaye ilandelelanisa i-YAP12.Oku kukufumanisa okunomdla njengoko kuthetha ukuba i-DGC ilawula umjikelo weseli ye-cardiomyocyte.I-α-DH kwi-cardiomyocytes ye-neonatal isebenzisana ne-agrin, ekhuthaza ukuvuselelwa kwentliziyo kunye ne-DGC76 lysis ngenxa yokuvuthwa kweeseli.Njengoko i-cardiomyocytes ikhula, intetho ye-aggrin iyancipha ngokuthanda i-lamin, ekucingelwa ukuba inegalelo ekubanjweni komjikelo weseli76.I-Morikawa12 ibonise ukuba i-double knockdown ye-dystrophin kunye ne-salvador, isilawuli esibi se-YAP, sikhokelela kwi-hyperproliferation ye-cardiomyocytes kwi-rumen ebangela i-infarct.Oku kukhokelele kumbono ochulumancisayo wokuba ukwenziwa kwe-YAP kunokuba nexabiso leklinikhi ekuthinteleni ukulahleka kwezicubu emva kwe-myocardial infarction.Ngaloo ndlela, i-agrin-induced DGC lysis inokumela i-axis evumela ukuba i-YAP isebenze kwaye iyindlela enokwenzeka yokuvuselelwa kwentliziyo.
Ngomatshini, i-α- kunye ne-β-DG iyadingeka ukugcina ukusebenzisana phakathi kwe-sarcolemma kunye ne-basal layer 81.Zomibini i-α-DG kunye ne-α7 integrins zinegalelo ekunyanzeliseni ukuveliswa kwi-ganglion ye-costal, kunye nokulahlekelwa kwe-α-DG kubangela ukuhlukana kwe-sarcolemma kwi-basal lamina, eshiya izicubu ze-skeletal muscle zisengozini kumonakalo owenziwe ukunqanda.Njengoko kuchazwe ngaphambili, i-complex ye-dystroglycan ilawula i-turnover yonke ye-DGCs, apho ukubopha kwi-cognate ligand laminin kubangela ukuba i-tyrosine phosphorylation ye-PPPY-binding motif ye-β-DG892.I-Tyrosine phosphorylation apha ikhuthaza i-dystrophin disassembly, eguqula i-DGC complex.I-Physiologically, le nkqubo ilawulwa kakhulu, engekhoyo kwi-muscular dystrophy82, nangona iindlela ezisisiseko ezilawula le nkqubo aziqondwa ngokupheleleyo.
I-Cyclic stretch ibonakaliswe ukuba isebenze i-ERK1 / 2 kunye neendlela ze-AMPK ngokusebenzisa i-dystrophin complex kunye ne-protein plectin83 ehambelana nayo.Ngokudibeneyo, i-plectin kunye ne-dystroglycan ayifunwa nje kuphela ukuba isebenze njenge-scaffold, kodwa kunye nokuthatha inxaxheba kwi-mechanotransduction, kunye ne-knockdown ye-plectin ikhokelela ekunciphiseni komsebenzi we-ERK1 / 2 kunye ne-AMPK83.I-Plectin iphinda ibophelele kwi-cytoskeletal intermediate filament desmin, kwaye i-desmin overexpression ibonakaliswe ukuphucula isifo se-phenotype kwi-mdx: i-desmin kunye ne-mdx iigundane, imodeli ye-DMD84 ephindwe kabini ye-mouse.Ngokusebenzisana ne-β-DG, i-plectin ibopha ngokungathanga ngqo i-DGC kule nxalenye ye-cytoskeleton.Ukongezelela, i-dystroglycan isebenzisana ne-protein-binding factor receptor-binding protein 2 (Grb2), eyaziwayo ukuba ibandakanyeka kwi-rearrangements ye-cytoskeletal85.Ukusebenza kweRas nge-integrin kubonakaliswe ukuba kulamlwa nge-Grb2, enokuthi ibonelele ngendlela enokubakho ye-crosstalk phakathi kwe-interins kunye ne-DGC86.
Ukuguqulwa kwezakhi zofuzo ezibandakanyekayo kwi-α-DH glycosylation kukhokelela kwinto ebizwa ngokuba yi-muscular dystrophy.I-Dystroglycanopathies ibonisa i-heterogeneity yeklinikhi kodwa ikakhulu ibangelwa ukuphazamiseka kwintsebenziswano phakathi kwe-α-DG kunye ne-lamin α277.I-Dystrophiglicanoses ebangelwa kukuguqulwa kweprayimari kwi-DAG1 inqabile kakhulu, mhlawumbi ngenxa yokuba i-embryonic lethal87, ngaloo ndlela iqinisekisa imfuno yobudlelwane beselula kunye ne-ECM.Oku kuthetha ukuba izifo ezininzi ze-dystrophic glycan zibangelwa ukuguqulwa kweprotheni yesibini ehambelana ne-glycosylation.Ngokomzekelo, ukuguqulwa kweenguqu kwi-POMT1 kubangela i-Walker-Warburg syndrome enzima kakhulu, ebonakaliswe yi-anencephaly kwaye iyancipha ngokuphawulekayo ixesha lokuphila (ngaphantsi kweminyaka eyi-3)88.Nangona kunjalo, iinguqu ze-FKRP zibonakaliswa kakhulu njenge-limb-girdle muscular dystrophy (LGMD), edla ngokuba (kodwa ingasoloko) incinci.Nangona kunjalo, utshintsho kwi-FKRP lubonakaliswe njengonobangela onqabileyo we-WWS89.Utshintsho oluninzi luye lwachongwa kwi-FKRP, apho umsunguli wenguquko (c.826> A) udla ngokubangela i-LGMD2I90.
I-LGMD2I yi-mild muscular dystrophy apho i-pathogenesis yayo isekelwe ekuphazamisekeni koqhagamshelwano phakathi kwe-matrix engaphandle kunye ne-intracellular cytoskeleton.Okungacacanga kakhulu ubudlelwane phakathi kwe-genotype kunye ne-phenotype kwizigulane ezinokuguqulwa kwezi zakhi zofuzo, kwaye ngokwenene le ngcamango iyasebenza kwezinye iiprotheni ze-DSC.Kutheni ezinye izigulana ezinotshintsho lwe-FKRP zibonisa isifo sephenotype esihambelana ne-WWS ngelixa ezinye zine-LGMD2I?Impendulo yalo mbuzo inokulala kwi-i) yeyiphi inyathelo lendlela ye-glycosylation echaphazelekayo kukuguqulwa, okanye ii) iqondo le-hypoglycosylation nakweliphi na inyathelo.I-Hypoglycosylation ye-α-DG isenokuthi ivumele iqondo elithile lokusebenzisana kunye ne-ECM ebangela ukuba kubekho i-phenotype epholileyo, ngelixa ukuhlukana kwi-membrane yangaphantsi kwandisa ubunzima be-phenotype yesifo.Izigulane ezine-LGMD2I ziphinda ziphuhlise i-DCM, nangona le nto ingaphantsi kwe-DMD, ikhuthaza ukuphuthuma kokuqonda oku kuguqulwa kumxholo we-cardiomyocytes.
I-sarcospan-sarcoglycan subcomplex ikhuthaza ukubunjwa kwe-DHA kwaye isebenzisana ngokuthe ngqo ne-β-DH.Kukho ezine sarcoglycans ezine unidirectional kwiithishu zentliziyo: α, β, γ, kunye ne-δ91.Kutshanje kuye kwachazwa ukuba i-c.218C>T missense ukuguqulwa kwe-exon 3 ye-SGCA gene kunye nokususwa kwe-heterozygous inxalenye kwi-exons 7-8 kubangela i-LGMD2D92.Nangona kunjalo, kule meko, ababhali abazange bahlole i-phenotype yenhliziyo.
Amanye amaqela afumene ukuba i-SGCD kwi-porcine93 kunye ne-mouse94 imodeli iphumela ekunciphiseni ukubonakaliswa kweprotheyini kwi-subcomplex ye-sarcoglycan, ukuphazamisa isakhiwo esipheleleyo se-DGC kunye nokukhokelela kwi-DCM.Ukongezelela, i-19% yazo zonke izigulane ezine-SGCA, SGCB, okanye i-SGCG yokuguqulwa kweenguqu zichazwe ukuba zine-cardiomyopathy edibeneyo, kwaye i-25% yazo zonke izigulane nazo zifuna inkxaso yokuphefumula95.
Ukuguqulwa okuphindaphindiweyo kwi-sarcoglycan (SG) δ kubangela ukunciphisa okanye ukungabikho ngokupheleleyo kwe-sarcoglycan complexes kwaye ngoko i-DGC kwizicubu zentliziyo kwaye inoxanduva lwe-LGMD kunye ne-DCM96 ehambelana nayo.Okubangel 'umdla kukuba, iinguqu ezilawulayo-ezimbi kwi-SG-δ zichanekileyo kwi-cardiovascular system kwaye ziyimbangela ye-familial dilated cardiomyopathy97.I-SG-δ i-R97Q kunye ne-R71T yokuguqulwa kwe-dominant-negative ibonakaliswe ngokuzinzileyo kwi-cardiomyocytes yegundane ngaphandle komonakalo obalulekileyo we-DGC98 iyonke.Nangona kunjalo, iiseli zentliziyo ezithwele olu tshintsho zichaphazeleka ngakumbi kumonakalo we-sarcolemma, ukunyanzeliswa, kunye nokungasebenzi kakuhle komatshini phantsi koxinzelelo lomatshini, oluhambelana ne-DCM98 phenotype.
I-Sarcospan (SSPN) yi-25 kDa tetraspanin ehlala kwi-subcomplex ye-sarcoglycan kwaye ikholelwa ukuba isebenza njenge-protein scaffold99,100.Njengeprotheyini ye-scaffold, i-SSPN izinzisa indawo yokuhlala kunye ne-glycosylation ye-α-DG99,101.Ukugqithiswa kwe-SSPN kwiimodeli zemouse kufunyenwe ukwandisa ukubopha phakathi kwe-muscle kunye ne-laminin 102.Ukongezelela, i-SSPN ibonakaliswe ukusebenzisana ne-interins, iphakamisa i-degree of crosstalk phakathi kwe-rib commissures ezimbini, i-DGC, kunye ne-integrin-talin-vinculin glycoprotein structure100,101,102.I-Knockdown ye-SSPN nayo ibangele ukwanda kwe-α7β1 kwi-mouse skeletal muscle.
Uphononongo olutshanje lubonise ukuba i-sarcospan overexpression ikhulisa ukuvuthwa kunye ne-glycosylation ye-α-DG kwizicubu zentliziyo ngokuzimeleyo kwi-galactosylaminotransferase 2 (Galgt2) i-knockdown kwimodeli ye-mdx ye-mouse ye-DMD, ngaloo ndlela inciphisa isifo se-phenotype 101. Ukwanda kwe-glycosylation ye-dystroglycan complex kunokunyusa i-interactivity ye-dystroglycan I-ECM, ngaloo ndlela inciphisa kakhulu isifo.Ngaphezu koko, baye babonisa ukuba i-sarcospan overexpression iyancipha ukusebenzisana kwe-β1D integrin kunye ne-DGCs, igxininisa indima enokwenzeka ye-sarcospan kulawulo lwe-integrin complexes101.
I-Syntrophins yintsapho encinci (i-58 kDa) iiprotheyini ezihlala kwi-DGCs, azinawo ngokwazo umsebenzi we-enzymatic wangaphakathi, kwaye zisebenza njenge-adapter molecular103,104.Ii-isoforms ezintlanu (α-1, β-1, β-2, γ-1 kunye ne-γ-2) ziye zachongwa ukubonisa inkcazo ye-tissue-specific, kunye ne-α-1 isoform echazwe ngokugqithiseleyo kwizicubu ze-muscle striated 105.I-Syntrophins zibalulekile iiprotheyini ze-adapter eziququzelela unxibelelwano phakathi kwe-dystrophin kunye neemolekyuli zokubonisa, kuquka neuronal nitric oxide synthase (nNOS) kwi-skeletal muscle106.I-α-syntrophin isebenzisana ngokuthe ngqo ne-dystrophin 16-17 i-spectin repeat domain, leyo ibophelela kwi-nNOS106,107 PDZ-binding motif.
I-Syntrophins iphinda idibanise ne-dystrobrevin ngokusebenzisa i-PH2 kunye ne-SU ezibophezelayo, kwaye ziphinde zidibanise ne-actin cytoskeleton 108.Enyanisweni, i-sytrophins ibonakala idlala indima ebaluleke kakhulu kulawulo lwe-cytoskeletal dynamics, kwaye i-α kunye ne-β isoforms ziyakwazi ukusebenzisana ngokuthe ngqo ne-F-actin 108 kwaye ngaloo ndlela zidlala indima ekulawuleni ubunzima kunye ne-biomechanics yeselula. isiphumo.Ukongezelela, i-sytrophins ibonakaliswe ukulawula i-cytoskeleton nge-Rac1109.
Ukumodareyitha amanqanaba e-syntrophin kunokubuyisela umsebenzi, kwaye uphando olutshanje olusebenzisa i-mini-dystrophin lubonise ukuba i-ΔR4-R23 / ΔCT yokwakha yakwazi ukubuyisela i-α-syntrophin kunye nezinye iiprotheni ze-DGC kumanqanaba athelekiswa ne-WT mdx cardiomyocytes.
Ukongeza kwindima yabo ekulawuleni i-cytoskeleton, i-sytrophins nayo ibhalwe kakuhle kulawulo lweziteshi ze-ion 111,112,113.I-PDZ-binding motif ye-sytrophins ilawula i-cardiac voltage-dependent-dependent-Nav1.5111 channel, edlala indima ephambili ekusekeni i-cardiac excitability and conduction.Kuyathakazelisa ukuba kwimodeli ye-mouse ye-mdx, iziteshi ze-Nav1.5 zifunyenwe ziphantsi kwaye i-cardiac arrhythmias ifunyenwe kwizilwanyana ze-111.Ukongezelela, intsapho yamajelo e-ion ye-mechanosensitive, i-channel ye-receptor enokuthi ifumaneke (TRPC), ibonakaliswe ukuba ilawulwa yi-α1-syntrophin kwi-cardiac tissue 113 kunye ne-TRPC6 inhibition iboniswe ukuphucula i-arrhythmias kwimodeli ye-mouse ye-DMD112.Ukunyuka komsebenzi we-TRPC6 kwi-DMD kuye kwabikwa ukuba kubangele i-cardiac arrhythmias, ekhululekayo xa idibene ne-PKG 112.Ngomatshini, ukuchithwa kwe-dystrophin kukhuthaza ukunyuka kwe-stretch-induced influx ye- [Ca2 +] i-isebenza phezulu kwe-TRPC6 ukuze isebenze, njengoko kuboniswe kwi-cardiomyocytes kunye ne-vascular smooth muscle cells112,114.I-Hyperactivation ye-TRPC6 yokwelula yenza i-mechanosensor enkulu kunye nethagethi enokubakho yonyango kwi-DMD112,114.
Ukulahlekelwa kwe-dystrophin kukhokelela kwi-lysis okanye ukunyanzeliswa okuphawulweyo kuyo yonke i-DGC eyinkimbinkimbi, kunye nokulahlekelwa okulandelayo kwemisebenzi emininzi ye-mechanoprotective kunye ne-mechanotransduction, okubangelwa yi-phenotype eyintlekele ebonwa kwizicubu ze-muscle ze-DMD.Ke ngoko, kunokuba sengqiqweni ukucinga ukuba ii-RSKs zisebenza kwikonsathi kwaye amalungu axhomekeke kubukho kunye nokusebenza kwamanye amacandelo.Oku kuyinyani ngokukodwa kwi-dystrophin, ebonakala ifuneka kwi-assembly kunye ne-localization ye-sarcolemma eyinkimbinkimbi kwi-cardiomyocytes.Icandelo ngalinye lidlala indima ekhethekileyo ekufakeni igalelo ekuzinziseni ngokubanzi kwe-sarcolemma, ukugcinwa kweeprotheyini eziphambili ze-accessory, ukulawulwa kweziteshi ze-ion kunye ne-gene expression, kunye nokulahlekelwa kweprotheni enye kwi-DGC kukhokelela ekudakaleni kwe-myocardium yonke.
Njengoko kuboniswe ngasentla, iiprotheni ezininzi ze-DGC zibandakanyeka kwi-mechanotransduction kunye nokubonakaliswa, kwaye i-dystrophin ifaneleka ngokukodwa kule ndima.Ukuba i-DGC ifumaneka kwiimbambo, oku kuqinisekisa uluvo lokuba ithatha inxaxheba kwi-mechanotransduction kunye ne-interins.Ke, ii-DGCs zihamba ngokwasemzimbeni ukuhanjiswa kwamandla e-anisotropic kwaye zithathe inxaxheba kwi-mechanosensory kunye ne-cytoskeletal rearrangement ye-intracellular microenvironment, ehambelana nemodeli ye-tensegrity.Ukongeza, i-Dp427m ikhusela amandla angenayo e-biomechanical ngokwandisa i-spectrin ephindaphindayo ngaphakathi kwendawo yayo engundoqo, ngokwenza oko isebenze njengomatshini wokukhusela ngokugcina amandla angama-25 pN wokukhulula kuluhlu olwandisiweyo lwe-800 nm.Ngokwahlula, i-dystrophin iyakwazi "ukuphazamisa" amandla okunciphisa i-contraction-relaxation eyenziwa yi-cardiomyocytes10.Ngenxa yokwahlukana kweeprotheyini kunye ne-phospholipids ezisebenzisana neendawo eziphindaphindayo ze-spectrin, kunomdla ukucinga ukuba i-spectrin iphinda i-unwinding iguqula i-kinetics ebophezelayo yeeprotheni ze-mechanosensitive ngendlela efana ne-talin116,117,118.Nangona kunjalo, oku akukaqinisekwa kwaye uphando olongezelelweyo luyafuneka.